InvestSMART

Immutep Limited (ASX: IMM) - Announcements

- Current share price for IMM : $0.046

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$68 Results of Meeting 22 Nov 2024 12:19PM $0.300 $0.046 fallen by 84.67%
$68 Immutep AGM 2024 - CEO's Presentation 22 Nov 2024 8:18AM $0.285 $0.046 fallen by 83.86%
$68 Immutep AGM 2024 - Chairman's Address 22 Nov 2024 8:18AM $0.285 $0.046 fallen by 83.86%
$68 Change in substantial holding 18 Nov 2024 4:52PM $0.315 $0.046 fallen by 85.40%
$68 Excellent Survival Data from INSIGHT-003 Trial in NSCLC 14 Nov 2024 9:06AM $0.310 $0.046 fallen by 85.16%
$68 Positive Data from Phase II Trial in Soft Tissue Sarcoma 14 Nov 2024 8:34AM $0.310 $0.046 fallen by 85.16%
$68 Becoming a substantial holder 14 Nov 2024 8:23AM $0.310 $0.046 fallen by 85.16%
$68 Immutep Quarterly Activities Report and Appendix 4C 29 Oct 2024 10:02AM $0.300 $0.046 fallen by 84.67%
$68 TACTI-003 Cohort B data to be presented at ESMO I-O 28 Oct 2024 10:13AM $0.293 $0.046 fallen by 84.27%
$68 Annual Report filed on Form 20-F with SEC 23 Oct 2024 8:23AM $0.300 $0.046 fallen by 84.67%
$68 Notice of Annual General Meeting/Proxy Form 22 Oct 2024 12:41PM $0.300 $0.046 fallen by 84.67%
$68 Appendix 4G and Corporate Governance Statement 22 Oct 2024 12:29PM $0.300 $0.046 fallen by 84.67%
$68 Annual Report to shareholders 22 Oct 2024 12:03PM $0.300 $0.046 fallen by 84.67%
$68 Ceasing to be a substantial holder 21 Oct 2024 7:32PM $0.300 $0.046 fallen by 84.67%
$68 Change in substantial holding 18 Oct 2024 8:21AM $0.305 $0.046 fallen by 84.92%
$68 Becoming a substantial holder 17 Oct 2024 7:48PM $0.305 $0.046 fallen by 84.92%
$68 IMP761 Progresses to Dose Escalation Portion of Ph1 Trial 17 Oct 2024 10:29AM $0.315 $0.046 fallen by 85.40%
$68 Appendix 3Z - Anne Anderson 14 Oct 2024 4:07PM $0.320 $0.046 fallen by 85.63%
$68 2024 AGM & Key Dates 10 Oct 2024 11:38AM $0.320 $0.046 fallen by 85.63%
$68 Resignation of Non-executive Director 4 Oct 2024 4:57PM $0.315 $0.046 fallen by 85.40%
$68 Enrolment for Ph II AIPAC-003 Breast Cancer Trial Completed 3 Oct 2024 9:50AM $0.320 $0.046 fallen by 85.63%
$68 Change of Director's Interest Notice - Pete Meyers 2 Oct 2024 2:47PM $0.323 $0.046 fallen by 85.74%
$68 Application for quotation of securities - IMM 1 Oct 2024 12:42PM $0.328 $0.046 fallen by 85.95%
$68 Ceasing to be a substantial holder 26 Sep 2024 7:00PM $0.345 $0.046 fallen by 86.67%
$68 Change in substantial holding from IFL 25 Sep 2024 3:29PM $0.338 $0.046 fallen by 86.37%

126 - 150 of 775 results

Page 6 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.